Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2020/10/07/biopharma-boosted-on-analyst-upgrade

10/7/2020 9:14 AM

The shares of PTC Therapeutics Inc (NASDAQ:PTCT) are up 3.8% at $51.50 in pre-market trading, after J.P. Morgan Securities upgraded the stock to "overweight" from "neutral," with an added price-targe...

2 Drug Stocks That Could Heat Up In July

https://www.schaeffersresearch.com/content/analysis/2018/06/26/2-drug-stocks-that-could-heat-up-in-july

6/26/2018 12:13 PM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and PTC Therapeutics, Inc. (NASDAQ:PTCT) are two drug stocks struggling today, with the former down 1.5% to trade at $325.28, and the latter down 5.5% to tr...

3 Drug Stocks Trading Near the Top of Nasdaq

https://www.schaeffersresearch.com/content/news/2018/06/18/3-drug-stocks-trading-near-the-top-of-nasdaq

6/18/2018 3:14 PM

Stocks are trading lower, with the Dow down triple digits with less than an hour to go in the session. However, a few names making positive moves today -- all near the top of Nasdaq -- include drug s...

3 Stocks Sinking on Downgrades

https://www.schaeffersresearch.com/content/news/2017/10/09/3-stocks-sinking-on-downgrades

10/9/2017 10:02 AM

Analysts are weighing in on healthcare firm Medtronic Plc (NYSE: MDT), video game stock Take-Two Interactive Software Inc (NASDAQ:TTWO), and biotech PTC Therapeutics, Inc. (NASDAQ:PTCT) . Here's a qu...

Equifax CEO Bows Out Before Testimony; PTCT Tanks After FDA Review

https://www.schaeffersresearch.com/content/news/2017/09/26/equifax-ceo-bows-out-before-testimony-ptct-tanks-after-fda-review

9/26/2017 3:31 PM

U.S. stocks are trading cautiously higher this afternoon, as the Dow attempts to bounce back from a three-day losing streak. Among the names in the spotlight today are beleaguered credit agency Equif...

PEOPLE ALSO SEARCH FOR